Status: Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.
Participants needed: 780
Trial details
Age: 18-100Biological sex: AllType: InterventionalSponsor: BrioHealth Solutions, Inc.Updated: Apr 1, 2026Locations: 37
Eligibility criteria
Patient is ≥ 18 years of age. [+8]
Patient's heart failure etiology is related to restrictive or constrictive physi... [+30]